HRP950268B1 - Pharmaceutical compositions containing gemfibrozil - Google Patents

Pharmaceutical compositions containing gemfibrozil

Info

Publication number
HRP950268B1
HRP950268B1 HRP9401506A HRP950268A HRP950268B1 HR P950268 B1 HRP950268 B1 HR P950268B1 HR P9401506 A HRP9401506 A HR P9401506A HR P950268 A HRP950268 A HR P950268A HR P950268 B1 HRP950268 B1 HR P950268B1
Authority
HR
Croatia
Prior art keywords
compositions containing
pharmaceutical compositions
gemfibrozil
subject matter
surfactant
Prior art date
Application number
HRP9401506A
Other languages
English (en)
Inventor
Zsuzsa Szlavy-Nee-Szell
Original Assignee
Zsuzsa Szlavy Nee Szell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zsuzsa Szlavy Nee Szell filed Critical Zsuzsa Szlavy Nee Szell
Publication of HRP950268A2 publication Critical patent/HRP950268A2/xx
Publication of HRP950268B1 publication Critical patent/HRP950268B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HRP9401506A 1994-05-13 1995-05-02 Pharmaceutical compositions containing gemfibrozil HRP950268B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9401506A HU212428B (en) 1994-05-13 1994-05-13 Process to prepare pharmaceutical compositions containing gemfibrozyl
US08/441,687 US5726201A (en) 1994-05-13 1995-05-15 Gemfibrozil containing pharmaceutical compositions

Publications (2)

Publication Number Publication Date
HRP950268A2 HRP950268A2 (en) 1997-08-31
HRP950268B1 true HRP950268B1 (en) 1999-02-28

Family

ID=26318196

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP9401506A HRP950268B1 (en) 1994-05-13 1995-05-02 Pharmaceutical compositions containing gemfibrozil

Country Status (17)

Country Link
US (1) US5726201A (fr)
EP (1) EP0684042B1 (fr)
JP (1) JP2934941B2 (fr)
AT (1) ATE160938T1 (fr)
AU (1) AU1768095A (fr)
CA (1) CA2149282A1 (fr)
CZ (1) CZ287149B6 (fr)
DE (1) DE69501183T2 (fr)
ES (1) ES2113136T3 (fr)
FR (1) FR2719771B1 (fr)
GB (1) GB2291349B (fr)
GR (1) GR3025749T3 (fr)
HR (1) HRP950268B1 (fr)
HU (1) HU212428B (fr)
IT (1) IT1274483B (fr)
PL (1) PL179806B1 (fr)
SK (1) SK279927B6 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2329334A (en) * 1997-09-18 1999-03-24 Reckitt & Colmann Prod Ltd Cholesterol-lowering agents
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
WO2002043694A2 (fr) 2000-11-28 2002-06-06 Fmc Corporation Composition d'enrobage comestible en alginate de propylene glycol
US6841865B2 (en) * 2002-11-22 2005-01-11 International Rectifier Corporation Semiconductor device having clips for connecting to external elements
NZ546337A (en) * 2003-10-31 2009-03-31 Takeda Pharmaceutical Solid preparation comprising an insulin sensitizer such as pioglitazone hydrochloride, an insulin secretagogue such as glimepiride and a polyoxyethylene sorbitan fatty acid ester such as Polysorbate 80

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3674836A (en) * 1968-05-21 1972-07-04 Parke Davis & Co 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof
US4126637A (en) * 1977-06-17 1978-11-21 Warner-Lambert Company Process for the production of 2,2-dimethyl-5-(2,5-xylyloxy)valeric acid
US4387107A (en) * 1979-07-25 1983-06-07 Dermik Laboratories, Inc. Stable benzoyl peroxide composition
EP0179583A1 (fr) * 1984-10-04 1986-04-30 Merck & Co. Inc. Système pour augmenter la vitesse de dissolution dans l'eau et la solubilité de médicaments peu solubles
US4971804A (en) * 1989-02-02 1990-11-20 Warner-Lambert Company Water dispersible gemfibrozil compositions
US4925676A (en) * 1989-02-02 1990-05-15 Warner-Lambert Company Extended release gemfibrozil composition
US4927639A (en) * 1989-02-02 1990-05-22 Warner-Lambert Company Modified release gemfibrozil composition
EP0462067A1 (fr) * 1990-06-15 1991-12-18 Warner-Lambert Company Formulations de gemfibrozil
EP0475894A1 (fr) * 1990-08-27 1992-03-18 Warner-Lambert Company Formulations améliorées de gemfibozile
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system

Also Published As

Publication number Publication date
EP0684042A2 (fr) 1995-11-29
CA2149282A1 (fr) 1995-11-14
EP0684042B1 (fr) 1997-12-10
DE69501183D1 (de) 1998-01-22
ITMI950961A1 (it) 1996-11-12
PL179806B1 (pl) 2000-10-31
GB2291349B (en) 1998-03-18
IT1274483B (it) 1997-07-17
GR3025749T3 (en) 1998-03-31
ITMI950961A0 (it) 1995-05-12
AU1768095A (en) 1995-11-23
SK60595A3 (en) 1996-05-08
JP2934941B2 (ja) 1999-08-16
ATE160938T1 (de) 1997-12-15
FR2719771B1 (fr) 1997-01-03
GB2291349A (en) 1996-01-24
EP0684042A3 (fr) 1996-05-15
FR2719771A1 (fr) 1995-11-17
HU212428B (en) 1996-06-28
HRP950268A2 (en) 1997-08-31
CZ287149B6 (en) 2000-09-13
CZ122895A3 (en) 1995-12-13
PL308580A1 (en) 1995-11-27
US5726201A (en) 1998-03-10
HUT70961A (en) 1995-11-28
SK279927B6 (sk) 1999-05-07
ES2113136T3 (es) 1998-04-16
HU9401506D0 (en) 1994-08-29
GB9509542D0 (en) 1995-07-05
DE69501183T2 (de) 1998-05-07
JPH0899875A (ja) 1996-04-16

Similar Documents

Publication Publication Date Title
MY115339A (en) Compositions containing micronized nebivolol
IL110582A0 (en) Substituted azadioxacycloalkenes, their preparation and fungicidal compositions containing them
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
KR100257803B1 (en) Stable hydrated cephalosporin dry powder for oral suspension formulation
MX9706647A (es) Composiciones farmaceuticas que comprenden inhibidores de oxidasa b de monoamina.
ATE148990T1 (de) Ebastin oder ebastin-analoga enthaltende arzneimittel
IL113178A0 (en) 8 alpha-3-hydroxyestra-1,3,5(11) tetraen-17-one (delta9(11)-dehydro-8 isoestrone its preparation andpharmaceutical composition containing it and its use
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
GB2291349B (en) Gemfibrozil containing pharmaceutical compositions
HUT53664A (en) Process for producing enzyme inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
AU555467B2 (en) Fatty cream
ES2006521A6 (es) Composicion de control de plagas procedimiento derivados benzopiranicos y benzotiopiranicos y metodo de preparar dicha composicion
EP0817643A4 (fr) Composes et compositions servant a l'apport d'agents actifs
HU214140B (hu) Hatóanyagként metalaxilt és ftálimidszármazékot tartalmazó fokozott biológiai hatású fungicid készítmény és eljárás felhasználására

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 19990502

Year of fee payment: 5

PBON Lapse due to non-payment of renewal fee

Effective date: 20000503